154 related articles for article (PubMed ID: 9324232)
1. Increased expression of midkine during the progression of human astrocytomas.
Mishima K; Asai A; Kadomatsu K; Ino Y; Nomura K; Narita Y; Muramatsu T; Kirino T
Neurosci Lett; 1997 Sep; 233(1):29-32. PubMed ID: 9324232
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody to human midkine reveals increased midkine expression in human brain tumors.
Kato S; Ishihara K; Shinozawa T; Yamaguchi H; Asano Y; Saito M; Kato M; Terada T; Awaya A; Hirano A; Dickson DW; Yen SH; Ohama E
J Neuropathol Exp Neurol; 1999 May; 58(5):430-41. PubMed ID: 10331431
[TBL] [Abstract][Full Text] [Related]
3. Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro.
Desbaillets I; Tada M; de Tribolet N; Diserens AC; Hamou MF; Van Meir EG
Int J Cancer; 1994 Jul; 58(2):240-7. PubMed ID: 7517920
[TBL] [Abstract][Full Text] [Related]
4. Midkine expression in transient retinal ischemia in the rat.
Miyashiro M; Kadomatsu K; Ogata N; Yamamoto C; Takahashi K; Uyama M; Muramatsu H; Muramatsu T
Curr Eye Res; 1998 Jan; 17(1):9-13. PubMed ID: 9472465
[TBL] [Abstract][Full Text] [Related]
5. Expression of vascular endothelial growth factor-b in human astrocytoma.
Gollmer JC; Ladoux A; Gioanni J; Paquis P; Dubreuil A; Chatel M; Frelin C
Neuro Oncol; 2000 Apr; 2(2):80-6. PubMed ID: 11303624
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
[TBL] [Abstract][Full Text] [Related]
7. Expression of the Ets-1 proto-oncogene correlates with malignant potential in human astrocytic tumors.
Kitange G; Kishikawa M; Nakayama T; Naito S; Iseki M; Shibata S
Mod Pathol; 1999 Jun; 12(6):618-26. PubMed ID: 10392639
[TBL] [Abstract][Full Text] [Related]
8. N-cadherin, beta-catenin and connexin 43 expression in astrocytic tumours of various grades.
Reszec J; Szkudlarek M; Hermanowicz A; Bernaczyk PS; Mariak Z; Chyczewski L
Histol Histopathol; 2015 Mar; 30(3):361-71. PubMed ID: 25386667
[TBL] [Abstract][Full Text] [Related]
9. Neurotrophic factor expression in childhood low-grade astrocytomas and ependymomas.
Chiaretti A; Aloe L; Antonelli A; Ruggiero A; Piastra M; Riccardi R; Tamburrini G; Di Rocco C
Childs Nerv Syst; 2004 Jun; 20(6):412-9. PubMed ID: 15138791
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of basic fibroblast growth factor in astrocytomas.
Zagzag D; Miller DC; Sato Y; Rifkin DB; Burstein DE
Cancer Res; 1990 Nov; 50(22):7393-8. PubMed ID: 2171762
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma.
Pećina-Šlaus N; Kafka A; Varošanec AM; Marković L; Krsnik Ž; Njirić N; Mrak G
Mol Med Rep; 2016 May; 13(5):4245-51. PubMed ID: 27035837
[TBL] [Abstract][Full Text] [Related]
12. Role of GalNAc4S-6ST in astrocytic tumor progression.
Kobayashi T; Yan H; Kurahashi Y; Ito Y; Maeda H; Tada T; Hongo K; Nakayama J
PLoS One; 2013; 8(1):e54278. PubMed ID: 23349846
[TBL] [Abstract][Full Text] [Related]
13. Expression and cellular localization of messenger RNA for plasminogen activator inhibitor type 1 in human astrocytomas in vivo.
Yamamoto M; Sawaya R; Mohanam S; Loskutoff DJ; Bruner JM; Rao VH; Oka K; Tomonaga M; Nicolson GL; Rao JS
Cancer Res; 1994 Jul; 54(13):3329-32. PubMed ID: 8012944
[TBL] [Abstract][Full Text] [Related]
14. Increased midkine expression in intrahepatic cholangiocarcinoma: immunohistochemical and in situ hybridization analyses.
Kato M; Shinozawa T; Kato S; Endo K; Terada T
Liver; 2000 Jun; 20(3):216-21. PubMed ID: 10902971
[TBL] [Abstract][Full Text] [Related]
15. Induction of midkine expression in reactive astrocytes following rat transient forebrain ischemia.
Mochizuki R; Takeda A; Sato N; Kimpara T; Onodera H; Itoyama Y; Muramatsu T
Exp Neurol; 1998 Jan; 149(1):73-8. PubMed ID: 9454616
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of urokinase and urokinase receptor genes in malignant astrocytoma.
Gladson CL; Pijuan-Thompson V; Olman MA; Gillespie GY; Yacoub IZ
Am J Pathol; 1995 May; 146(5):1150-60. PubMed ID: 7747809
[TBL] [Abstract][Full Text] [Related]
17. Role of gemistocytes in astrocytoma progression.
Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
[TBL] [Abstract][Full Text] [Related]
18. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
[TBL] [Abstract][Full Text] [Related]
19. Expression pattern of alpha-protein kinase C in human astrocytomas indicates a role in malignant progression.
Benzil DL; Finkelstein SD; Epstein MH; Finch PW
Cancer Res; 1992 May; 52(10):2951-6. PubMed ID: 1316231
[TBL] [Abstract][Full Text] [Related]
20. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
